Literature DB >> 2067661

The use of immunosuppressive agents in the treatment of multiple sclerosis: a critical review.

D S Goodin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2067661     DOI： 10.1212/wnl.41.7.980

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Primary CNS demyelinating diseases in childhood: multiple sclerosis.

Authors:  P Iannetti; M G Marciani; A Spalice; F Spanedda; U Raucci; G Trasimeni; G F Gualdi; G Bernardi
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

Review 2.  Does a placebo-effect exist in clinical trials on multiple sclerosis? Review of the literature.

Authors:  L La Mantia; M Eoli; A Salmaggi; C Milanese
Journal:  Ital J Neurol Sci       Date:  1996-04

3.  Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological Society.

Authors:  A Ghezzi; L M E Grimaldi; M G Marrosu; C Pozzilli; G Comi; A Bertolotto; M Trojano; P Gallo; R Capra; D Centonze; E Millefiorini; S Sotgiu; V Brescia Morra; M P Amato; A Lugaresi; G Mancardi; D Caputo; E Montanari; L Provinciali; L Durelli; R Bergamaschi; P Bellantonio; M R Tola; S Cottone; G Savettieri; G Tedeschi
Journal:  Neurol Sci       Date:  2011-04       Impact factor: 3.307

4.  High dose methylprednisolone in severe acute transverse myelopathy.

Authors:  G Sébire; H Hollenberg; L Meyer; G Huault; P Landrieu; M Tardieu
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

Review 5.  Adrenoleukodystrophy: phenotypic variability and implications for therapy.

Authors:  H W Moser; A B Moser; K D Smith; A Bergin; J Borel; J Shankroff; O C Stine; C Merette; J Ott; W Krivit
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  An analysis of peripheral type benzodiazepine receptors on blood mononuclear cells during high dose steroid treatment of multiple sclerosis.

Authors:  P Ferrero; P Rocca; P Benna; C De Leo; E Montalenti; L Ravizza; B Bergamasco
Journal:  Ital J Neurol Sci       Date:  1992-11

7.  Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.

Authors:  S M Alam; T Kyriakides; M Lawden; P K Newman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

8.  Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.

Authors:  F Barkhof; M W Tas; S T Frequin; P Scheltens; O R Hommes; J J Nauta; J Valk
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.